Summary
Introduction
The effect on pancreatic secretion of introducing bile or bile salts into the duodenum has been studied by several workers 11-91, but the results have been conflicting. Some have found that bile salts stimulate pancreatic secretion 1, 3,4,6-91, whereas others have described no effect [21 or an inhibition [2, 3, 5, 61. Much less attention has been paid to the effect of bile salts on biliary secretion. Forell et al. [41 reported that during duodenal infusion with sodium glycocholate in man, bilirubin was absent from the duodenal Auid, and Wormsley [31 noticed that although pancreatic secretion was stimulated by bile salts introduced into the duodenum in man, bilirubin secretion remained unchanged. These workers did not describe the effect of bile salts on biliary secretion further. Malagelada et al. 15, 61 found, however, that bile salts in the duodenum suppressed biliary secretion stimulated by amino acids or fatty acids, but no effect on basal or exogenously stimulated secretion was noticed
151.
In the present work we have studied the effect of the bile salt sodium taurocholate on biliary and pancreatic secretion in man, both in-the basal state and during background stimulation with either intravenous caerulein and secretin or luminal essential amino acids. Plasma levels of several gastrointestinal hormones, known to be released from the upper gastrointestinal tract and the pancreas, were monitored throughout the studies.
Methods

Perfusion technique
The duodenal perfusion technique has been described in detail before 1101. The recovery marker [polyethylene glycol: PEG 4000; 5 g/l in NaCl solution (150 mmol/l)] was infused into the duodenum opposite the ampulla of Vater at the rate of 10 ml/min. This solution was used as a vehicle for sodium taurocholate (STC) and essential amino acids (EAA) during different phases of the experiments. A continuous aspiration of the duodenal fluid was carried out close to the ligament of Treitz (1 8 cm perfusion segment) by using an aspiration tube with wide air ventile (2 m m inner diameter) to ensure efficient continuous suction. Gastric aspiration was carried out with a standard gastric aspiration technique with phenol red as a recovery marker [ 1 11. Intravenous cannulae were positioned into antecubital veins of each arm for collection of blood and infusion of gastrointestinal hormones respectively. Fully informed, written consent was obtained from every volunteer and all human experiments were approved by the Royal Postgraduate Medical School Research Ethics Committee.
Preparation of infusion and perfusion solutions
Secretin and caerulein were diluted in sterile NaCl solutions (150 mmol/l), containing 200 pmol of human serum albumin/l, and infused intravenously at doses of 2-5 ng h-l kg-' (caerulein) and 0.025 clinical unit h-' kg-I (secretin) (for clinical units of secretin, see Instruments and chemicals, below). Perfusates of NaCl solution (150 mmol/l), STC (10 mmol/l), EAA (78 mmol/l) and a mixture of STC and EAA (10/78 mmol/l) were prepared immediately before use, made iso-osmolar (290 mosmol/ kg) with NaCl solution and adjusted to pH 6.3 with NaOH or HCI and warmed to 37OC before use. All perfusates contained PEG 4000, 5 g/l, as a duodenal marker. Phenol red was dissolved and diluted in distilled water to final concentration of 1.5 g/l for gastric perfusion.
Experimental design
The experiments were planned to study the effect of duodenal perfusion with STC on basal and stimulated biliary and pancreatic secretion in man. The effects on plasma levels of gastrointestinal hormones were also studied. Duodenal perfusion with EAA was used to provide an endogenous stimulus for biliary and pancreatic secretion, and caerulein and secretin were administered by continuous intravenous infusion as exogenous stimuli for the secretion. The following series of studies were carried out.
Eflects of STC and EAA on basal secretion. The effects of STC and EAA on basal biliary and pancreatic secretion were studied in five healthy volunteers (ages 21-24 years). After 2 h duodenal perfusion with NaCl (150 mmolh) (equilibration period), STC (10 mmol/l) was perfused for 4 h, followed by a perfusion of EAA (78 mmol/l) and STC (10 mmol/l) in combination for 1 h. In a separate group of studies, the prolonged effect of EAA (78 mmol/l) on basal secretion was studied in five volunteers (ages 20-24 years). The EAA perfusion lasted for 3 h and was preceded by an equilibration period of 2 h, where the duodenum was perfused with NaCl (150 mmol/l) alone. In a third group of studies (12 subjects, ages 20-25 years), the basal bilirubin and trypsin secretion were monitored for 6 h during duodenal perfusion with NaCl (1 5 0 mmol/l) alone.
Eflects of STC and EAA on exogenously stimulated secretion. The effects of STC and EAA on exogenously stimulated biliary and pancreatic secretion were studied in eight volunteers (ages 23-30 years), who received an intravenous infusion of caerulein (2.5 ng h-' kg-') and secretin (0.025 clinical unit h-' kg-') for 6 h. During this time the duodenum was perfused for the first 2 h with NaCl solution (1 50 mmol/l) alone (equilibration period). This was followed by a perfusion with STC (10 mmol/l) for 1 h, followed by a perfusion with EAA (78 mmol/l) and STC (10 mmol/l) in combination for 1 h, followed during the final hour with a perfusion of EAA (78 mmol/l) alone. As a control study, duodenal perfusion with NaCl (150 mmol/l) alone was carried out for 6 h in 12 volunteers (ages 20-25 years), who received the same caerulein/secretin stimulation as described above.
Instruments and chemicals
Aspiration pumps for gastric and duodenal aspiration were obtained from Air Shields Inc. The EAA mixture was exactly the same as used by previous workers [51. STC was synthesized in our laboratory as described by Lack et al. [ 121 with the following modifications: after refluxing the mixture of taurine (British Drug House Chemicals Ltd), cholic acid (Sigma, London) and EEDQ (N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline ethyl-1,Zdihydro-2-ethoxy-1-quinoline-carboxylate) (Aldrich Chemical Co. Inc., U.K.) for 24 h, ethanol was evaporated from the mixture in a rotary vacuum evaporator. The residue was transferred to a separating funnel, dissolved in water and washed three times with dichloromethane. The aqueous extract was freeze-dried. The freeze-dried material was dissolved in ethanol and precipitated by addition of ethyl acetate and finally allowed to crystallize over several days at -2OOC. The product was tested by a thin-layer chromatography and proved to migrate as a single spot identical with an STC standard (Sigma T4009, London).
Sample processing and analytical methods
Blood samples for hormone measurements were collected at 10-20 min intervals into heparin-treated tubes containing aprotinin, centrifuged immediately (1500 g for 10 min) and the plasma was kept frozen at -2OOC until assayed.
Duodenal aspirates were pooled for 10 min on ice in darkness, and aliquots saved in dark-brown bottles for analysis of bilirubin, PEG 4000, trypsin, total bile salts and phenol red. A portion was collected separately into a narrow airtight container and sealed by a 1 cm layer of liquid p a r d n for analysis of bicarbonate. Gastric aspirates were pooled on ice for 10 min, and the samples frozen until analysed for phenol red and PEG 4000. Bilirubin [131, trypsin (101, total bile salts [lo, 141, PEG 4000 1151 and phenol red [ 1 11 were measured by methods described elsewhere. Bicarbonate was measured by addition of hydrochloric acid, boiling and back-titration. Calculation of total secretion of bilirubin, total bile salts and trypsin were based on standard equations for PEG 4000 recovery 161.
Motilin was measured with an N-terminal reacting porcine antiserum 11 71, which detected both large and small molecular forms of motilin in plasma 1181 and showed no cross-reactivity with other hormones. Changes of 3 pmol of motilin/l of plasma could be detected with 95% confidence. Pancreatic polypeptide (PP) [ 101 was measured with an antiserum raised against bovine pancreatic polypeptide. The assay detected changes in PP concentration of 8 pmol/l with 95% confidence. Gastric inhibitory polypeptide (GIP) was measured with a C-terminal-reacting porcine antiserum, which detected large and small molecular forms of GIP in plasma without cross-reactivity with other hormones 191. Changes of 2.5 pmolll of plasma were detected with 95% confidence. Gastrin was measured with antiserum raised against human gastrin, which detected changes in gastrin plasma levels of 2 pmol/l with 95% confidence [201.
Statistical analysis was performed by using Student's t-test for paired or unpaired data, as appropriate, or two-way analysis of variance. Since the data on biliary and pancreatic secretion and gastrointestinal hormones were not normally distributed, but approximately log normal, all statistical evaluation of these data was done on log values. The data are expressed in the text, 
Results
Recovery of the gastric marker (phenol red) from the stomach and the duodenum Studies with duodenal perfusion only. NaCl control group: recovery from the stomach 75.7% f SEM 2.4 (n = 12) and the duodenum 13.8% f 2.4 (n = 12); STC test group: recovery from the stomach 80.4% & 6.1 (n = 5 ) and the duodenum 21.6% f 4.5 (n = 5): EAA test group: recovery from the stomach 72.9% f 4.9 ( n = 5 ) and the duodenum 22.3% & 5.8 (n = 5).
Studies with duodenal perfusion and caeruleinlsecretin stimulation. NaCl control group: recovery from the stomach 87.6% f SEM 2.9 (n = 12) and the duodenum 11.6% f 2.6 (n = 12); STC test group: recovery from the stomach 75.1% f 5.3 ( n = 8 ) and the duodenum 24.5% f 3-2 (n = 8) ( P < 0.01 cornpared with control group, 11.6% & 2.6). Recovery of the duodenal marker (PEG 4000) from the duodenum and the stomach Studies with duodenal perfusion only. NaCl control group: recovery from the duodenum 54.2% f SEM 7.0 (n = 12) and the stomach 10.3% f 2.9 ( n = 12); STC test group: recovery from the duodenum 49.2% t 4.0 (n = 5) and the stomach 17.1% f 4.2 ( n = 5); EAA test group: recovery from the duodenum 53.9% f 12.8 (n = 5) and the stomach 22.5% f 11.3 ( n = 5).
Studies with duodenal perfusion and caeruleinlsecretin stimulation. NaCl control group: recovery from the duodenum 59.2% 4 SEM 6.5 (n = 12) and the stomach 4.4% f 1 -1 (n = 12); STC test group: recovery from the duodenum 52.1% f 8.7 ( n = 8) and the stomach 11.8% f 4-4 (n = 8).
Statistically, there was no significant difference in recovery of either gastric or duodenal markers between the test groups and the appropriate control groups, with the exception of duodenal recovery of phenol red in the caeruleinl secretin STC group and the control group ( P < 0.01, see above).
Eflects of STC and EAA on basal secretion
Basal bilirubin secretion fell promptly from 389 pUgll0 min (262-583, n = 5) during the hour immediately preceding STC perfusion to 23 p g / l O min (14-38, n = 5) ( P < 0.001) during the second half of the first STC perfusion hour (Fig.  la) . During the following 3 h of STC perfusion, a progressive increase in bilirubin secretion was observed, the bilirubin secretion during the fourth hour of STC perfusion being 333 ,ug/lO min (195-578, n = 5) and not significantly different from the basal levels. During a subsequent perfusion for 1 h with EAAISTC in combination, bilirubin secretion rose markedly above these levels to 1195 p g I l 0 min (740-2095, n = 5) ( P < 0-01) (Fig. la) , suggesting that gallbladder Bicarbonate secretion did not change during the 4 h of STC perfusion (Table 1) but, during the final hour when EAA and STC were perfused together, a trivial but statistically significant increase in bicarbonate secretion was observed (P < 0.05) ( Table 1 ). The concentrations of total bile salts in the duodenum during the 4 consecutive hours of STC perfusion were 6.4 mmol/l (5.8-7.0), 6.4 mmol/l (6-3-6.5): 6.2 mmol/l (5.3-7.2) and 6.0 mmol/l (5.0-7.3) respectively, compared with 0.7 mmol/l (0-3-1 -0) during the basal period when NaCl (150 mmol/l) was perfused alone. In the control group no abrupt changes in bilirubin secretion were observed, although there was a downward trend in secretion during the 6 h of NaCl (150 mmol/l) perfusion. However, a wide variation in basal bilirubin secretion was observed between the control group and the STC test group. Inherent individual variation in basal bilirubin secretion is a likely explanation to this rather than a difference in marker recovery.
Eflects of prolonged EAA stimulation
Bilirubin secretion rose from 486 pg/10 min (257-927, n = 5) during the basal period to a peak value of 2727 pg/lO rnin (2428-3055, n = 5) 20 rnin after the beginning of EAA perfusion (P < 0.02). Subsequently, bilirubin secretion fell to a plateau of 1392 pg/lO min (1055-1716, n = 6) during the second and third hours of EAA perfusion (Fig. 3a) (5164-7674, P < 0.02, compared with pre-STC hour), falling before the EAA/STC perfusion was completed and failing to rise again during perfusion with EAA alone (Fig. 46) . A slight increase in bicarbonate secretion was observed during the perfusion of STC alone and EAA/ STC in combination compared with the initial NaCl perfusion (P < 0.05) ( Table 1 ).
In the control studies without STC perfusion, caerulein/secretin-stimulated bilirubin and trypsin secretion remained stable throughout 6 h (Fig. 5) .
Plasma levels of gastrointestinal hormones
Plasma levels of gastrin, GIP and PP did not change during STC perfusion in either the basal or exogenously stimulated studies. However, EAA in combination with STC, or perfused alone, revealed an increase in plasma PP levels (Figs. 6 and 7) (P < 0.05). Plasma levels of motilin were significantly suppressed (P < 0401) in both basal and exogenously stimulated studies during STC perfusion (Figs. 6 and 7) ; however, levels rose again when EAA were added to the perfusate.
Discussion
Perfusion of the duodenum with the bile salt STC suppressed the secretion of bilirubin into the duodenum, both in the basal state and during The anatomical location and mechanism of this inhibitory effect can only be explained in a limited way by our data. Bilirubin secretion into the duodenum depends on hepatic secretory rate, the fraction of bile entering the gallbladder and the amount of bile accommodated in the biliary tract. Inhibition of bile output was observed as early as 1&20 min after the beginning of the STC perfusion and is therefore unlikely to be caused by a direct action on the hepatic secretion by absorbed STC passing through the liver. 151 , using luminal EAA as a background stimulus, found that STC suppressed stimulated biliary and pancreatic secretion but that STC did not inhibit the biliary response to intravenous cholecystokinin, and concluded that STC may inhibit endogenous cholecystokinin release from the duodenum. Differences in the endogenous and exogenous stimuli doses probably account for these apparently contradictory results. The caerulein/secretin stimulus used in our studies could be expected to simulate the combined cholecystokinetic [391 and choleretic (401 effects seen after a meal and these were inhibited by STC. The absence of any effect of STC on pancreatic secretion and the apparently normal biliary and pancreatic responses to luminal EAA during STC perfusion suggest that STC acts through a mechanism different from inhibition of cholecystokinin release.
The short-lived or phasic trypsin secretory response to EAA during STC perfusion was also observed during control studies with EAA perfusion alone. This pattern of enzyme response to EAA has been observed before and attributed to a 'wash-out' of stored enzymes 15, 161, or to a stimulation of glucagon release by absorbed EAA and a secondary inhibition of enzyme secretion [4 11. Although frequently referred to, the 'washout' effect has never actually been proven to exist 1421, and it is unlikely to explain the phasic enzyme response following the prolonged period of exogenous caerulein/secretin stimulation, which would have depleted enzyme stores (Fig.  4) . It should also be pointed out in these studies that trypsin secretion during EAA/STC and EAA perfusion superimposed on caerulein/ secretin stimulation never did fall below the plateau obtained by caerulein and secretin, which suggests that the mechanism of EAA and caerulein/secretin-induced secretion is different.
Although STC had no effect on pancreatic trypsin secretion, nor any effect on basal bicarbonate output, a modest increase in caeruleinl secretin-stimulated bicarbonate output was observed. Other workers have shown that human bile [71 or pure bile salt mixtures simulating the composition of human bile 1431 may increase bicarbonate secretion and plasma levels of secretin immunoreactivity and, in the cat, where STC is the major bile salt, an effect on bicarbonate secretion was observed 1441. Although our results do not support the idea that STC on its own stimulates bicarbonate secretion in man, it may act additively with the caerulein/ secretin-stimulated bicarbonate secretion (Table  l) , a concept which has support from previous work [3, 4, 44] .
The selective inhibition of biliary secretion during duodenal perfusion with STC supports the concept that duodenal bile salt concentration may be one of the luminal factors regulating bile delivery to the duodenum. The role of motilin has not been defined in these studies though plasma levels of this hormone fell in parallel with the biliary inhibition.
